packageCaptodiame

captodiame

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Captodiame is a diphenylmethane derivative classified as an anxiolytic, indicating it was used to treat anxiety. It is currently listed only as an experimental compound, with no authorisation records available, so its current availability is unclear.

Summary written by glm-5.3-flash from Wikidata Q2937681 and the WHO ATC classification; not checked by a person.

name:captodiame
ATC codes:N05BB02
DrugBank:DB09014
PubChem CID:10240
ChEBI:135521
Wikidata:Q2937681
formula:C21H29NS2
molar mass:359.59 g/mol (PubChem CID 10240)
logP:5.9 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown